Abstract
B-cell lymphoproliferative disorders are rare but serious complications of solid organ and bone marrow transplantation. We report that these tumors frequently express the CD-20 antigen, and immunotherapy directed at this antigen may be a well-tolerated and effective treatment. (C) 2000 Wiley-Liss, Inc.
Original language | English (US) |
---|---|
Pages (from-to) | 171-173 |
Number of pages | 3 |
Journal | American Journal of Hematology |
Volume | 65 |
Issue number | 2 |
DOIs | |
State | Published - Oct 5 2000 |
Externally published | Yes |
Keywords
- CD-20
- Post-transplant lymphoproliferative disorder
- PTLD
- Rituximab
ASJC Scopus subject areas
- Hematology